Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bioventus (BVS) Receivables - Other (2020 - 2025)

Bioventus' Receivables - Other history spans 6 years, with the latest figure at $177000.0 for Q4 2025.

  • For Q4 2025, Receivables - Other rose 132.89% year-over-year to $177000.0; the TTM value through Dec 2025 reached $177000.0, up 132.89%, while the annual FY2025 figure was $177000.0, 132.89% up from the prior year.
  • Receivables - Other reached $177000.0 in Q4 2025 per BVS's latest filing, up from $76000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $50.0 million in Q4 2021 to a low of $76000.0 in Q4 2024.
  • Average Receivables - Other over 5 years is $8.2 million, with a median of $257000.0 recorded in 2023.
  • Peak YoY movement for Receivables - Other: skyrocketed 225.61% in 2022, then plummeted 70.43% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $82000.0 in 2021, then surged by 225.61% to $267000.0 in 2022, then fell by 3.75% to $257000.0 in 2023, then crashed by 70.43% to $76000.0 in 2024, then surged by 132.89% to $177000.0 in 2025.
  • Per Business Quant, the three most recent readings for BVS's Receivables - Other are $177000.0 (Q4 2025), $76000.0 (Q4 2024), and $6.5 million (Q3 2024).